Axolotl Biosciences-preview

Axolotlbiosciences

Axolotl Biosciences

Private

Victoria, British ColumbiaHealthcare & Life Scienceshttps://www.axolotlbiosciences.com/

Last Round

Grant

Nov 21, 2024

Total Funding Raised

$499,000

Momentum Score

25 /100

Company Overview

Axolotl Biosciences is a biotechnology company that develops and provides bio-inks, 3D tissue models, and consulting services for 3D bioprinting to be used in tissue engineering and regenerative medicine.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Advanced Materials, Drug Discovery, 3D Printing

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

bioink3D bioprintinghuman tissue modelneural bioinkdrug discoveryinduced pluripotent stem cellshiPSCsregenerative medicinebiotech consumablesanimal testing alternativedrug screeningtissue engineeringbiofabrication3D cell culturedisease modeling

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Axolotl Biosciences Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Axolotl Biosciences Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Nov 21, 2024
Seed	Jan 31, 2023
Grant	Jan 18, 2023
Grant	Jul 8, 2022
Grant	Sep 1, 2021
Grant	Jun 17, 2021

View all Funding Rounds

Key People

Founding team and executive leadership

Stephanie Willerth

Chief Executive Officer

Executive Team

Axolotl Biosciences Investors

Notable investors and investment history

Investor	Rounds
National Research Council Canada Industrial Research Assistance Program	Grant
AM Ventures	Grant
National Research Council of Canada	Grant
Innovate BC	Grant
Next Generation Manufacturing Canada (NGen)	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

May 2, 2025
Monthly visitors grew 283% MoM, reaching 1K.
Nov 21, 2024
Raised $5K from AM Ventures

View all signals

Axolotl Biosciences Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Axolotl Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Axolotl Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersVictoria, British Columbia

Employee Range9

Year Founded2020

Last FundingNov 21, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.